|
|
|
|
LEADER |
01000caa a22002652 4500 |
001 |
NLM234309156 |
003 |
DE-627 |
005 |
20250216130646.0 |
007 |
tu |
008 |
231224s2013 xx ||||| 00| ||chi c |
028 |
5 |
2 |
|a pubmed25n0781.xml
|
035 |
|
|
|a (DE-627)NLM234309156
|
035 |
|
|
|a (NLM)24406233
|
040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
041 |
|
|
|a chi
|
100 |
1 |
|
|a Shu, Lin-hua
|e verfasserin
|4 aut
|
245 |
1 |
0 |
|a Alterations of SP-A, SP-D and KL-6 in serum and bronchoalveolar lavage fluid in children with Mycoplasma pneumoniae pneumonia
|
264 |
|
1 |
|c 2013
|
336 |
|
|
|a Text
|b txt
|2 rdacontent
|
337 |
|
|
|a ohne Hilfsmittel zu benutzen
|b n
|2 rdamedia
|
338 |
|
|
|a Band
|b nc
|2 rdacarrier
|
500 |
|
|
|a Date Completed 24.07.2014
|
500 |
|
|
|a Date Revised 07.06.2016
|
500 |
|
|
|a published: Print
|
500 |
|
|
|a Citation Status MEDLINE
|
520 |
|
|
|a OBJECTIVE: To study the alterations and relationship of surfactant protein (SP)-A, SP-D and KL-6 in serum and bronchoalveolar lavage fluids (BALF) in children with Mycoplasma pneumoniae pneumonia (MPP)
|
520 |
|
|
|a METHOD: Self-control method was used for the study on SP-A, SP-D and KL-6 in serum, infected and non-infected BALFs in 32 MMP children with only one side of MPP
|
520 |
|
|
|a RESULT: The contents of SP-A, SP-D and KL-6 in infected BALF were [mg/L;M (IQR) ]: 243 (90-468) , 187 (43-333) , 148 (47-426) ;104 (37-257) , 56 (25-131) , 35 (12-147) in non-infected BALF; 35 (25-69) , 33 (9-149) and 24 (15-62) in serum. The correlation coefficient of KL-6 between serum and infected BALF were -0.534 and -0.378 (P < 0.05)
|
520 |
|
|
|a CONCLUSION: There were significant correlation between the alterations of SP-A, SP-D and KL-6 in serum and lung infection in children with CAP. KL-6 in serum may be more sensitive than SP-A and SP-D
|
650 |
|
4 |
|a English Abstract
|
650 |
|
4 |
|a Journal Article
|
650 |
|
4 |
|a Research Support, Non-U.S. Gov't
|
650 |
|
7 |
|a Biomarkers
|2 NLM
|
650 |
|
7 |
|a MUC1 protein, human
|2 NLM
|
650 |
|
7 |
|a Mucin-1
|2 NLM
|
650 |
|
7 |
|a Pulmonary Surfactant-Associated Protein A
|2 NLM
|
650 |
|
7 |
|a Pulmonary Surfactant-Associated Protein D
|2 NLM
|
700 |
1 |
|
|a Shang, Yun-xiao
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Cai, Xu-xu
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Zong, Zhi-hong
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Meng, Xiao-na
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Zhang, Han
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Wang, Zhi-jia
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Dai, Bing
|e verfasserin
|4 aut
|
773 |
0 |
8 |
|i Enthalten in
|t Zhonghua er ke za zhi = Chinese journal of pediatrics
|d 1960
|g 51(2013), 10 vom: 09. Okt., Seite 779-82
|w (DE-627)NLM136249191
|x 0578-1310
|7 nnns
|
773 |
1 |
8 |
|g volume:51
|g year:2013
|g number:10
|g day:09
|g month:10
|g pages:779-82
|
912 |
|
|
|a GBV_USEFLAG_A
|
912 |
|
|
|a SYSFLAG_A
|
912 |
|
|
|a GBV_NLM
|
912 |
|
|
|a GBV_ILN_11
|
912 |
|
|
|a GBV_ILN_20
|
912 |
|
|
|a GBV_ILN_22
|
912 |
|
|
|a GBV_ILN_24
|
912 |
|
|
|a GBV_ILN_31
|
912 |
|
|
|a GBV_ILN_39
|
912 |
|
|
|a GBV_ILN_40
|
912 |
|
|
|a GBV_ILN_50
|
912 |
|
|
|a GBV_ILN_61
|
912 |
|
|
|a GBV_ILN_65
|
912 |
|
|
|a GBV_ILN_69
|
912 |
|
|
|a GBV_ILN_70
|
912 |
|
|
|a GBV_ILN_72
|
912 |
|
|
|a GBV_ILN_120
|
912 |
|
|
|a GBV_ILN_130
|
912 |
|
|
|a GBV_ILN_227
|
912 |
|
|
|a GBV_ILN_244
|
912 |
|
|
|a GBV_ILN_285
|
912 |
|
|
|a GBV_ILN_294
|
912 |
|
|
|a GBV_ILN_350
|
912 |
|
|
|a GBV_ILN_665
|
912 |
|
|
|a GBV_ILN_813
|
951 |
|
|
|a AR
|
952 |
|
|
|d 51
|j 2013
|e 10
|b 09
|c 10
|h 779-82
|